21/09/2026
๐๐ฉ๐ฐ Denmark-based Novo Nordisk is expanding its drug pipeline, aiming to bring more blockbuster treatments to market by 2030, with a focus on diabetes and obesity care.
Designed to Follow world news as it shifts across Politics, Markets, Innovation, Sports, Movies, and Global Growth.
Tirunelveli
| Monday | 9am - 6am |
| Tuesday | 9am - 6am |
| Wednesday | 9am - 6am |
| Thursday | 9am - 6am |
| Friday | 9am - 6am |
| Saturday | 9am - 6am |
Be the first to know and let us send you an email when Uchchi posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.